Just bought today. Key for me -
Full year guidance has been affirmed; – H1 FY19 underlying EBITDA for the Group was $9.6m and full year guidance is a range of $27.5m - $30.5m
– a recovery in the Enterprise division in H2 underpins the achievement of guidance
• We are on-track at the end of H1 FY19 and momentum is building with each month
Looking at the Bell Potter research, previous underlying Evita guidance was 22 - 25m. New guidance is 27.5 - 30.5m Evita. Much better. I think it is way undervalued and will be a positive re-rate from brokers tomorrow.
Ann: 2019 Half Year Results Investor Presentation, page-6
Add 5GN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.26M | |||
| Open | High | Low | Value | Volume |
| 14.3¢ | 15.0¢ | 14.3¢ | $15.76K | 108.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 134676 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 2129010 | 23 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| 5GN (ASX) Chart |